Tirzepatide (LY3298176)

The Dual-Incretin Breakthrough: The Science of Tirzepatide

Tirzepatide is a pioneering synthetic peptide that represents the “twincretin” class of metabolic modulators. While traditional research focused on selective GLP-1 agonists, Tirzepatide is engineered to provide a dual-agonist approach, targeting both the Glucagon-like Peptide-1 (GLP-1) and Glucose-dependent Insulinotropic Polypeptide (GIP) receptors. Its structure is primarily based on the endogenous GIP amino acid sequence, modified with a C20 fatty diacid moiety to extend its biological half-life, making it a highly stable and potent subject for longitudinal metabolic studies.

Mechanism of Action:

Tirzepatide’s dual agonism creates a synergistic effect that exceeds the capabilities of mono-receptor agonists. By binding to both incretin receptors, it influences metabolic pathways through multiple vectors:

1. GIP Receptor Agonism: GIP is the primary incretin hormone. In the presence of Tirzepatide, GIP signaling enhances insulin secretion and, critically, improves the sensitivity of adipose tissue to metabolic signals, which may protect against ectopic fat deposition.

2. GLP-1 Receptor Agonism: Activation of the GLP-1 receptor slows gastric emptying and acts on the brain’s satiety centers (the hypothalamus) to reduce appetite. It also suppresses post-meal glucagon secretion.

3. Synergistic Glycemic Control: The combined action leads to a glucose-dependent increase in insulin secretion, significantly lowering blood glucose levels without the high risk of hypoglycemia seen with other agents.

Technical Specifications:

• Sequence: 39-amino acid modified peptide (GIP-based backbone)

• CAS Number: 2023788-19-2

• Molecular Formula: $C_{225}H_{348}N_{48}O_{68}$

• Molecular Weight: $4813.5 \, g/mol$

• Purity: >99% (HPLC & MS Verified)

• Form: Lyophilized Powder (5mg)

• Reconstitution: Must be reconstituted with Bacteriostatic Water (BAC)

Applications in Human Research:

Tirzepatide is currently the focal point of the most advanced research in endocrinology and cardiology:

• Superior Weight Loss Research: Investigating the “synergy effect” that allows Tirzepatide to achieve more significant weight reduction in clinical models compared to selective GLP-1 agonists.

• Type 2 Diabetes Homeostasis: Studies focus on the restoration of first- and second-phase insulin secretion and the long-term stabilization of HbA1c levels.

• Cardiovascular & NASH Studies: Analyzing the compound’s potential to reduce liver fat content and systemic inflammatory markers associated with heart disease.

• Energy Homeostasis: Researching how dual agonism influences resting energy expenditure and nutrient partitioning.

The Swiss Chems Scientific Standard

When you look for Tirzepatide for sale, the complexity of its 39-amino acid sequence and fatty acid side chain requires absolute manufacturing precision. Minor structural deviations can significantly alter its affinity for the GIP vs. GLP-1 receptors. At Swiss Chems, we guarantee that our Tirzepatide is strictly third-party lab tested via HPLC and Mass Spectrometry to ensure a minimum purity of 99% and exact sequence verification.

Our lyophilized 5mg vials are vacuum-sealed to ensure stability. Buy online today from the Official Swiss Chems website and secure the high-purity dual-incretin agonists required for the cutting edge of metabolic research.